Sustainability | July 10, 2024
Synexa Life Sciences enrolls in My Green Lab Certification Program
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The My Green Lab Certification is the gold standard for laboratory sustainability practices worldwide
The academy has secured partnerships with 15 esteemed hospitals
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
This existing GMP compliant facility, located at Bharuch (Unit-1) with ongoing expansion part of the company's strategic capex initiative
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated
